Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,628
datasets available to search
ShareScore release 0.9.0
Dataset results
1,628 results for “type safety”
A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy
ClinicalTrials.gov study NCT01399580. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin
ClinicalTrials.gov study NCT02926950. IPD Sharing: YES. Countries: 4. Publications: 0.
A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00612794. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type
ClinicalTrials.gov study NCT01245166. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life
ClinicalTrials.gov study NCT02111135. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
ClinicalTrials.gov study NCT04885712. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00099918. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00963768. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients
ClinicalTrials.gov study NCT04079413. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin
ClinicalTrials.gov study NCT03066830. IPD Sharing: YES. Countries: 10. Publications: 0.
Efficacy and Safety of a New Botulinum Toxin Type A for Treatment of Facial Expression Lines
ClinicalTrials.gov study NCT01180348. IPD Sharing: YES. Countries: 1. Publications: 19.
Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy
ClinicalTrials.gov study NCT05794139. IPD Sharing: NO. Countries: 8. Publications: 0.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphon
ClinicalTrials.gov study NCT00755287. IPD Sharing: Not stated. Countries: 27. Publications: 1.
Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
ClinicalTrials.gov study NCT00499707. IPD Sharing: Not stated. Countries: 7. Publications: 0.
First-time Usage of SGLT2 Inhibitors in Type 2 Diabetic Patients Who Are Fasting During Ramadan: Safety and Efficacy
ClinicalTrials.gov study NCT06370247. IPD Sharing: NO. Countries: 1. Publications: 1.
Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)
ClinicalTrials.gov study NCT01059825. IPD Sharing: YES. Countries: 0. Publications: 2.
Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
ClinicalTrials.gov study NCT00621140. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
ClinicalTrials.gov study NCT00099320. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
ClinicalTrials.gov study NCT01263483. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00138554. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.